ArticleBreast cancer research and treatment2023

A specific anti-cyclin D1 intrabody represses breast cancer cell proliferation by interrupting the cyclin D1-CDK4 interaction.

Jialiang Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.